Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Lucid Diagnostics Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +6 vs. Q2 2023
- Shares held
- 1.92M
- +51.3K (+2.8%) vs. Q2 2023
- Total value
- $2.24M
- −$350.9K (−13.5%) vs. Q2 2023
- New holders
- 7
- 4 more added
- Sold out
- 1
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LUCD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 115 | $65.7M |
| Q1 2026 | 103 | $41.0M |
| Q4 2025 | 89 | $35.1M |
| Q3 2025 | 86 | $35.6M |
| Q2 2025 | 72 | $21.9M |
| Q1 2025 | 49 | $14.1M |
| Q4 2024 | 33 | $2.80M |
| Q3 2024 | 29 | $2.00M |
| Q2 2024 | 34 | $1.74M |
| Q1 2024 | 30 | $1.69M |
| Q4 2023 | 25 | $2.67M |
| Q3 2023 | 24 | $2.24M |
| Q2 2023 | 18 | $2.59M |
| Q1 2023 | 19 | $2.49M |
| Q4 2022 | 23 | $2.60M |
| Q3 2022 | 23 | $3.58M |
| Q2 2022 | 31 | $5.55M |
| Q1 2022 | 32 | $9.09M |
| Q4 2021 | 35 | $17.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Lucid Diagnostics Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Luminus Management LLC | 875,100 | $1.02M | 0.32% | −3,278−0.4% | Reduced |
| Vanguard Group Inc | 325,566 | $380.9K | 0.00% | +5,733+1.8% | Added |
| Nantahala Capital Management, LLC | 158,135 | $185.0K | 0.02% | −40,939−20.6% | Reduced |
| Bridgeway Capital Management, LLC | 135,000 | $157.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 131,871 | $154.3K | 0.00% | −11,594−8.1% | Reduced |
| Ayrton Capital LLC | 73,907 | $86.5K | 0.59% | +73,907 | New |
| Citadel Advisors LLC | 36,375 | $42.6K | 0.00% | −26,136−41.8% | Reduced |
| Verition Fund Management LLC | 36,166 | $42.3K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 33,850 | $39.6K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 28,400 | $33.2K | 0.00% | +14,000+97.2% | Added |
| BlackRock Inc. | 23,741 | $27.8K | 0.00% | −2,563−9.7% | Reduced |
| Jane Street Group, LLC | 17,322 | $20.3K | 0.00% | +17,322 | New |
| State Street Corp | 10,521 | $12.3K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,077 | $10.6K | 0.00% | +8,983+9,556.4% | Added |
| Byrne Asset Management LLC | 7,210 | $8.00K | 0.01% | +7,210 | New |
| UBS Group AG | 5,516 | $6.45K | 0.00% | +5,516 | New |
| Tower Research Capital LLC (TRC) | 2,991 | $3.50K | 0.00% | +2,964+10,977.8% | Added |
| Advisor Group Holdings, Inc. | 2,000 | $2.34K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1,920 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 200 | $234 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 174 | $204 | 0.00% | +174 | New |
| Qube Research & Technologies Ltd | 104 | $122 | 0.00% | +104 | New |
| JPMorgan Chase & Co | 13 | $15 | 0.00% | +13 | New |
| Hantz Financial Services, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 0 | $0 | 0.00% | −95−100.0% | Sold out |